Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/20.500.12008/52100

Título:

Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis

Otros títulos:

Coordinador:

Director:

Compilador:

Autor:

Bautista-Molano, Wilson
Fernández-Ávila, Daniel G.
Brance, María Lorena
Ávila Pedretti, María Gabriela
Burgos-Vargas, Ruben
Corbacho, Inés
Cosentino, Vanesa Laura
Díaz Coto, José Francisco
Giraldo Ho, Enrique
Gomes Resende, Gustavo
Gutiérrez, Luis Arturo
Gutiérrez, Marwin
Ibáñez Vodnizza, Sebastián Eduardo
Jáuregui, Edwin
Ocampo, Vanessa
Palleiro Rivero, Daniel Ruben

Tutor:

Tipo de documento:

Artículo

Editor:

Palabras clave:

Descriptores:

ANTIRREUMÁTICOS
USOS TERAPÉUTICOS
ESPONDILOARTRITIS AXIAL
PRODUCTOS BIOLÓGICOS
REUMATOLOGÍA
DIAGNÓSTICO
ADMINISTRACIÓN DEL TRATAMIENTO FARMACOLÓGICO
ESPONDILOARTROPATÍAS
ESPONDILITIS ANQUILOSANTE

Año de publicación:

2023

Contenido:

Resumen:

Axial spondyloarthritis (axSpA) comprises a spectrum of chronic inflammatory manifestations affecting the axial skeleton and represents a challenge for diagnosis and treatment. Our objective was to generate a set of evidence-based recommendations for the management of axSpA for physicians, health professionals, rheumatologists and policy decision makers in Pan American League of Associations for Rheumatology (PANLAR) countries. Grading of Recommendations, Assessment, Development and Evaluation-ADOLOPMENT methodology was used to adapt existing recommendations after performing an independent systematic search and synthesis of the literature to update the evidence. A working group consisting of rheumatologists, epidemiologists and patient representatives from countries within the Americas prioritized 13 topics relevant to the context of these countries for the management of axSpA. This Evidence-Based Guideline article reports 13 recommendations addressing therapeutic targets, the use of NSAIDs and glucocorticoids, treatment with DMARDs (including conventional synthetic, biologic and targeted synthetic DMARDs), therapeutic failure, optimization of the use of biologic DMARDs, the use of drugs for extra-musculoskeletal manifestations of axSpA, non-pharmacological interventions and the follow-up of patients with axSpA.

Descripción:

metadata.articulos.dc.description.uri:

Editorial:

Nature

EN:

Nature Reviews Rheumatology. Nov. 2023;19(11):724-737

Financiadores:

Citación:

Bautista-Molano W, Fernández-Ávila D, Brance M y otros. Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis. Nature Reviews Rheumatology [en línea]. Nov. 2023;19(11):724-737

Citación:

metadata.articulos.cc.license.name:

ISBN:

e-ISBN:

ISSN:

1759-4804

ISMN:

Otros identificadores:

Cobertura geográfica:

Cobertura temporal:

Departamento académico:

Grupo de investigación:

Licencia:

Licencia Creative Commons Atribución (CC - By 4.0)

Colecciones:

Publicaciones Académicas y Científicas
FicherosDescripciónTamañoFormato
Pan American League of Associations for Rheumatology.pdf Pan American League of Associations for Rheumatology 1.27 MB Adobe PDF
Mostrar el registro Dublin Core completo del ítem